These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16297347)

  • 21. Therapeutic equine hyperimmune antibodies with high and broad-spectrum neutralizing activity protect rodents against SARS-CoV-2 infection.
    Li E; Han Q; Bi J; Wei S; Wang S; Zhang Y; Liu J; Feng N; Wang T; Wu J; Yang S; Zhao Y; Liu B; Yan F; Xia X
    Front Immunol; 2023; 14():1066730. PubMed ID: 36875106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation by indirect immunofluorescent assay and enzyme linked immunosorbent assay of the dynamic changes of serum antibody responses against severe acute respiratory syndrome coronavirus.
    Mo HY; Xu J; Ren XL; Zeng GQ; Tan YX; Chen RC; Chan-Yeung M; Zhong NS
    Chin Med J (Engl); 2005 Mar; 118(6):446-50. PubMed ID: 15788124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity of SARS inactivated vaccine in BALB/c mice.
    Xiong S; Wang YF; Zhang MY; Liu XJ; Zhang CH; Liu SS; Qian CW; Li JX; Lu JH; Wan ZY; Zheng HY; Yan XG; Meng MJ; Fan JL
    Immunol Lett; 2004 Sep; 95(2):139-43. PubMed ID: 15388253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of severe acute respiratory syndrome-associated coronavirus infection by equine neutralizing antibody in golden Syrian hamsters.
    Zhao G; Ni B; Jiang H; Luo D; Pacal M; Zhou L; Zhang L; Xing L; Zhang L; Jia Z; Lin Z; Wang L; Li J; Liang Y; Shi X; Zhao T; Zhou L; Wu Y; Wang X
    Viral Immunol; 2007; 20(1):197-205. PubMed ID: 17425434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serological analysis of SARS Coronavirus in children diagnosed clinically as severe acute respiratory syndrome cases during SARS epidemic in Beijing].
    Zhao LQ; Qian Y; Zhu RN; Deng J; Wang F; Chen HZ; Cao L; Wang TY; Zhang T
    Zhonghua Er Ke Za Zhi; 2006 Apr; 44(4):262-6. PubMed ID: 16780645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.
    Pinto D; Park YJ; Beltramello M; Walls AC; Tortorici MA; Bianchi S; Jaconi S; Culap K; Zatta F; De Marco A; Peter A; Guarino B; Spreafico R; Cameroni E; Case JB; Chen RE; Havenar-Daughton C; Snell G; Telenti A; Virgin HW; Lanzavecchia A; Diamond MS; Fink K; Veesler D; Corti D
    Nature; 2020 Jul; 583(7815):290-295. PubMed ID: 32422645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison among four kits in detection of anti-SARS-CoV IgG in sera of SARS patients].
    Liu XE; Li J; Li YH; Wang L; Li T; Lu HY; Wang GF; Zhu WF; Gao XM; Wang YC; Zhao ZD; Xu XY; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):514-6. PubMed ID: 15231132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines.
    He Y; Zhu Q; Liu S; Zhou Y; Yang B; Li J; Jiang S
    Virology; 2005 Mar; 334(1):74-82. PubMed ID: 15749124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyclonal F(ab')
    Cunha LER; Stolet AA; Strauch MA; Pereira VAR; Dumard CH; Gomes AMO; Monteiro FL; Higa LM; Souza PNC; Fonseca JG; Pontes FE; Meirelles LGR; Albuquerque JWM; Sacramento CQ; Fintelman-Rodrigues N; Lima TM; Alvim RGF; Marsili FF; Caldeira MM; Zingali RB; de Oliveira GAP; Souza TML; Silva AS; Muller R; Rodrigues DDRF; Jesus da Costa L; Alves ADR; Pinto MA; Oliveira AC; Guedes HLM; Tanuri A; Castilho LR; Silva JL
    iScience; 2021 Nov; 24(11):103315. PubMed ID: 34723156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Equine immunoglobulin F(ab')
    Cui Z; Li D; Yi S; Guo Y; Dong G; Niu J; Zhao H; Zhang Y; Zhang S; Cao L; Wang K; Zhao Y; Hu G
    Int Immunopharmacol; 2019 Oct; 75():105714. PubMed ID: 31352323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus.
    Woo PC; Lau SK; Tsoi HW; Chen ZW; Wong BH; Zhang L; Chan JK; Wong LP; He W; Ma C; Chan KH; Ho DD; Yuen KY
    Vaccine; 2005 Oct; 23(42):4959-68. PubMed ID: 15993989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production and characterization of anti-human IgG F(ab')2 antibody fragment.
    Valedkarimi Z; Nasiri H; Aghebati-Maleki L; Abdolalizadeh J; Esparvarinha M; Majidi J
    Hum Antibodies; 2018; 26(4):171-176. PubMed ID: 29689714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two-way antigenic cross-reactivity between severe acute respiratory syndrome coronavirus (SARS-CoV) and group 1 animal CoVs is mediated through an antigenic site in the N-terminal region of the SARS-CoV nucleoprotein.
    Vlasova AN; Zhang X; Hasoksuz M; Nagesha HS; Haynes LM; Fang Y; Lu S; Saif LJ
    J Virol; 2007 Dec; 81(24):13365-77. PubMed ID: 17913799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study on the changing regularity of special antibody and expression of stomach and enteric involvement on SARS-coronavirus infection in the recovery period of severe acute respiratory syndrome].
    Shi YL; Li LH; Sun ZH; Chen JY; Liao Y; Zeng LL; Zhang W; Chen XD; Cao C
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Jul; 31(7):795-9. PubMed ID: 21162846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A preliminary investigation on the serological and epidemiological characteristics of severe acute respiratory syndrome in children].
    Cao L; Wang TY; Chen HZ; Qian Y; Chen BW; Fang P; Sun YX; Zhu RN; Deng J; Zhao LQ; Mi J; Zhang T
    Zhonghua Er Ke Za Zhi; 2004 Nov; 42(11):840-4. PubMed ID: 15631713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant nucleocapsid protein-based IgG enzyme-linked immunosorbent assay for the serological diagnosis of SARS.
    Saijo M; Ogino T; Taguchi F; Fukushi S; Mizutani T; Notomi T; Kanda H; Minekawa H; Matsuyama S; Long HT; Hanh NT; Kurane I; Tashiro M; Morikawa S
    J Virol Methods; 2005 May; 125(2):181-6. PubMed ID: 15794988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants.
    ter Meulen J; van den Brink EN; Poon LL; Marissen WE; Leung CS; Cox F; Cheung CY; Bakker AQ; Bogaards JA; van Deventer E; Preiser W; Doerr HW; Chow VT; de Kruif J; Peiris JS; Goudsmit J
    PLoS Med; 2006 Jul; 3(7):e237. PubMed ID: 16796401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of immunoglobulin G responses to the spike and nucleocapsid proteins of severe acute respiratory syndrome (SARS) coronavirus in patients with SARS.
    Zhao J; Wang W; Wang W; Zhao Z; Zhang Y; Lv P; Ren F; Gao XM
    Clin Vaccine Immunol; 2007 Jul; 14(7):839-46. PubMed ID: 17475765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Passive immunotherapy for Middle East Respiratory Syndrome coronavirus infection with equine immunoglobulin or immunoglobulin fragments in a mouse model.
    Zhao Y; Wang C; Qiu B; Li C; Wang H; Jin H; Gai W; Zheng X; Wang T; Sun W; Yan F; Gao Y; Wang Q; Yan J; Chen L; Perlman S; Zhong N; Zhao J; Yang S; Xia X
    Antiviral Res; 2017 Jan; 137():125-130. PubMed ID: 27890674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice.
    Lu B; Huang Y; Huang L; Li B; Zheng Z; Chen Z; Chen J; Hu Q; Wang H
    Immunology; 2010 Jun; 130(2):254-61. PubMed ID: 20406307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.